June 28, 2024 07:00 AM EDTUpdated 03:23 PM

Autoimmune brain disease startup Arialys gets new leader; Intellia, Arvinas appoint CFOs

Alex Hoffman

Copy Chief

Kathy Wong

Editor

Lei Lei Wu

News Reporter

Peter Flynn has taken the helm from Avalon BioVentures managing partner Jay Lichter at Arialys Therapeutics, a startup that is developing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Autoimmune brain disease startup Arialys gets new leader; Intellia, Arvinas appoint CFOs

Alex Hoffman

Copy Chief

Kathy Wong

Editor

Lei Lei Wu

News Reporter

Sign up to read this article for free.

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

CBER's deputy director departs as staff shakeup continues

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

Pfizer CEO says opportunities with Trump ‘clearly outweigh’ the risks for pharma

Trump blog: Judge extends nationwide block on NIH payment cuts

RFK Jr. readies review of childhood vaccine schedule after pledging not to

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

Au­toim­mune brain dis­ease start­up Ar­ialys gets new leader; In­tel­lia, Arv­inas ap­point CFOs

Copy Chief

Editor

News Reporter

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Autoimmune brain disease startup Arialys gets new leader; Intellia, Arvinas appoint CFOs